• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

建立并应用于接受持续肾脏替代治疗患者的感染预防与控制体系。

Establishment and application of an infection prevention and control system for patients undergoing continuous renal replacement therapy.

作者信息

Zhao Zhongjing, Zhao Huijie, Yang Yang, Wang Yuncong, Zhao Xia

机构信息

Division of Healthcare-Associated Infection Management, Xuanwu Hospital, Capital Medical University, Beijing, China.

出版信息

Front Med (Lausanne). 2025 Jul 7;12:1506188. doi: 10.3389/fmed.2025.1506188. eCollection 2025.

DOI:10.3389/fmed.2025.1506188
PMID:40692956
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12277335/
Abstract

BACKGROUND

Continuous renal replacement therapy (CRRT) is essential for critically ill patients but carries a high risk of hospital-acquired infections. Implementing an effective infection prevention and control system is critical for improving patient safety.

METHODS

This study utilized the Delphi method to develop a comprehensive infection prevention and control indicator system specifically designed for CRRT patients. A total of 126 patients treated at Xuanwu Hospital, Capital Medical University from January to December 2023 were included in the study. They were divided into a control group ( = 62), which received standard care, and an observation group ( = 64), which adopted the newly developed indicator system. Adverse event rates and nursing quality scores were compared between the two groups.

RESULTS

The final indicator system consisted of 3 primary, 9 secondary, and 27 tertiary indicators, with expert consensus reflected by a reliability coefficient of 0.795. The observation group demonstrated a significantly lower incidence of adverse events (3.12% vs. 16.12%, < 0.05) and higher nursing quality scores across three dimensions (basic care, equipment management, and nursing safety) compared to the control group ( < 0.05).

CONCLUSION

The infection prevention and control indicator system for CRRT patients exhibited strong reliability and scientific validity. Its implementation led to a significant reduction in infection rates and improvements in nursing quality, highlighting its potential for broader clinical adoption.

摘要

背景

连续性肾脏替代治疗(CRRT)对危重症患者至关重要,但存在医院获得性感染的高风险。实施有效的感染预防与控制体系对于提高患者安全至关重要。

方法

本研究采用德尔菲法制定了专门针对CRRT患者的综合感染预防与控制指标体系。纳入了2023年1月至12月在首都医科大学宣武医院接受治疗的126例患者。将他们分为对照组(n = 62),接受标准护理,以及观察组(n = 64),采用新制定的指标体系。比较两组的不良事件发生率和护理质量评分。

结果

最终的指标体系由3个一级指标、9个二级指标和27个三级指标组成,可靠性系数为0.795反映了专家共识。与对照组相比,观察组的不良事件发生率显著更低(3.12%对16.12%,P < 0.05),并且在三个维度(基础护理、设备管理和护理安全)上的护理质量评分更高(P < 0.05)。

结论

CRRT患者感染预防与控制指标体系具有很强的可靠性和科学有效性。其实施导致感染率显著降低和护理质量提高,凸显了其在更广泛临床应用中的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f304/12277335/9d828dee5824/fmed-12-1506188-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f304/12277335/9d828dee5824/fmed-12-1506188-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f304/12277335/9d828dee5824/fmed-12-1506188-g001.jpg

相似文献

1
Establishment and application of an infection prevention and control system for patients undergoing continuous renal replacement therapy.建立并应用于接受持续肾脏替代治疗患者的感染预防与控制体系。
Front Med (Lausanne). 2025 Jul 7;12:1506188. doi: 10.3389/fmed.2025.1506188. eCollection 2025.
2
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
3
Intervention measures to improve the filter life of continuous renal replacement therapy in critically ill patients-A systematic review.改善危重症患者连续性肾脏替代治疗滤器使用寿命的干预措施——一项系统评价
Nurs Crit Care. 2025 Jul;30(4):e13225. doi: 10.1111/nicc.13225. Epub 2024 Dec 9.
4
The measurement and monitoring of surgical adverse events.手术不良事件的测量与监测
Health Technol Assess. 2001;5(22):1-194. doi: 10.3310/hta5220.
5
Development and implementation of an "Internet " integrated service model for antepartum, intrapartum, and postpartum care in maternal and child specialty hospitals: A randomized controlled trial.妇幼专科医院产前、产时和产后护理“互联网+”综合服务模式的开发与实施:一项随机对照试验
Digit Health. 2025 Jul 20;11:20552076251357657. doi: 10.1177/20552076251357657. eCollection 2025 Jan-Dec.
6
Does Augmenting Irradiated Autografts With Free Vascularized Fibula Graft in Patients With Bone Loss From a Malignant Tumor Achieve Union, Function, and Complication Rate Comparably to Patients Without Bone Loss and Augmentation When Reconstructing Intercalary Resections in the Lower Extremity?对于因恶性肿瘤导致骨缺损的患者,在重建下肢节段性切除时,采用带血管游离腓骨移植来增强照射后的自体骨移植,其骨愈合、功能及并发症发生率与无骨缺损且未进行增强的患者相比是否相当?
Clin Orthop Relat Res. 2025 Jun 26. doi: 10.1097/CORR.0000000000003599.
7
Reduction Rate of Uric Acid in Blood during Continuous Renal Replacement Therapy for Acute Kidney Injury: A Multicenter Retrospective Observational Study.急性肾损伤持续肾脏替代治疗期间血尿酸的降低率:一项多中心回顾性观察研究
Blood Purif. 2025;54(2):83-92. doi: 10.1159/000542329. Epub 2024 Oct 29.
8
Management of urinary stones by experts in stone disease (ESD 2025).结石病专家对尿路结石的管理(2025年结石病专家共识)
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.
9
Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.阿德福韦酯与聚乙二醇化干扰素α-2a治疗慢性乙型肝炎:系统评价与经济学评估
Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. doi: 10.3310/hta10280.
10
Are Current Survival Prediction Tools Useful When Treating Subsequent Skeletal-related Events From Bone Metastases?当前的生存预测工具在治疗骨转移后的骨骼相关事件时有用吗?
Clin Orthop Relat Res. 2024 Sep 1;482(9):1710-1721. doi: 10.1097/CORR.0000000000003030. Epub 2024 Mar 22.

本文引用的文献

1
Enhancing Quality Control in Continuous Renal Replacement Therapy Through ICU Specialist Nursing Care Management Program.通过 ICU 专科护理管理方案提高连续性肾脏替代治疗中的质量控制。
Altern Ther Health Med. 2024 Feb;30(2):160-165.
2
Research on the Application Effect of Strengthening Risk Management in Continuous Renal Replacement Therapy Nursing of Critically Ill Patients.强化风险管理在危重症患者连续性肾脏替代治疗护理中的应用效果研究
Evid Based Complement Alternat Med. 2022 Jul 8;2022:2363877. doi: 10.1155/2022/2363877. eCollection 2022.
3
Continuous renal replacement therapy versus intermittent hemodialysis as first modality for renal replacement therapy in severe acute kidney injury: a secondary analysis of AKIKI and IDEAL-ICU studies.
连续性肾脏替代治疗与间歇性血液透析作为严重急性肾损伤肾脏替代治疗的一线治疗方法比较:AKIKI 和 IDEAL-ICU 研究的二次分析。
Crit Care. 2022 Apr 4;26(1):93. doi: 10.1186/s13054-022-03955-9.
4
Early fluid management affects short-term mortality in patients with end-stage kidney disease undergoing chronic hemodialysis and requiring continuous renal replacement therapy.早期液体管理影响终末期肾病行慢性血液透析且需要持续肾脏替代治疗患者的短期死亡率。
BMC Nephrol. 2022 Mar 14;23(1):102. doi: 10.1186/s12882-022-02725-7.
5
Metformin-associated Lactic Acidosis Successfully Treated with Continuous Renal Replacement Therapy.连续性肾脏替代疗法成功治疗二甲双胍相关乳酸酸中毒
Cureus. 2019 Aug 6;11(8):e5330. doi: 10.7759/cureus.5330.
6
Risk Factors of Central Venous Catheter-Related Bloodstream Infection for Continuous Renal Replacement Therapy in Kidney Intensive Care Unit Patients.肾内科重症监护病房患者连续肾脏替代治疗中中心静脉导管相关血流感染的危险因素。
Blood Purif. 2019;48(2):175-182. doi: 10.1159/000495024. Epub 2018 Nov 28.
7
Infection in critically ill pediatric patients on continuous renal replacement therapy.接受持续肾脏替代治疗的危重症儿科患者的感染情况。
Int J Artif Organs. 2017 May 29;40(5):224-229. doi: 10.5301/ijao.5000587. Epub 2017 May 18.
8
Continuous Renal Replacement Therapy Update: An Emphasis on Safe and High-Quality Care.连续性肾脏替代治疗的进展:强调安全与高质量护理
AACN Adv Crit Care. 2017 Spring;28(1):31-40. doi: 10.4037/aacnacc2017816.
9
Continuous Renal Replacement Therapies: Raising the Bar for Quality Care.连续性肾脏替代治疗:提升优质护理标准
AACN Adv Crit Care. 2017 Spring;28(1):28-40. doi: 10.4037/aacnacc2017235.
10
Risk factors for central line-associated bloodstream infection in pediatric oncology patients with a totally implantable venous access port: A cohort study.完全植入式静脉输液港的儿科肿瘤患者中心静脉导管相关血流感染的危险因素:一项队列研究。
Pediatr Blood Cancer. 2017 Feb;64(2):336-342. doi: 10.1002/pbc.26225. Epub 2016 Sep 26.